SEC Filing Details

Document Details

Form
Filing Date
Dec 6, 2019
Document Date
Nov 6, 2019
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Innate Pharma
Issuer
Innate Pharma SA